Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165425 · ClinicalTrials.gov registry record · NA
Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
A NA study of Hodgkin's Disease, sponsored by Dana-Farber Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 2
- Study locations
NCT00165425: Active NA study of Hodgkin's Disease, sponsored by Dana-Farber Cancer Institute.
NCT00165425 is a NA study of Hodgkin's Disease that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 210 participants, roughly in line with the 227-participant average among 20 other Hodgkin's Disease trials with a reported enrollment target. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00165425, a NA study of Hodgkin's Disease, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 2
- Study locations
Study Summary
The main purpose of this study is to determine if it is possible to put into practice a cardiac screening program for survivors of Hodgkin's disease. In this study, we would also like to screen for cardiac risk factors that can be modified either through life-style changes or medications, to uncover significant abnormal heart findings in which treatments may be needed, and to see if there is a link between cardiac health and quality of life.
Primary Outcome
Compliance of screening and follow up visits are tracked
Conditions Studied
Interventions
- PROCEDURE Echo/Stress Echo
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2004-02 |
| Est. Completion | 2028-12 |
| Phase | NA |
What the registry record for NCT00165425 still lists
NCT00165425 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 227-participant average among 20 other Hodgkin's Disease trials with a reported enrollment target.
The record links to 1 condition, with Hodgkin's Disease appearing as the primary indexed condition, and to 1 intervention - of which Echo/Stress Echo is the first listed.
NCT00165425 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00165425 about?
NCT00165425 is a clinical study titled "Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation". The main purpose of this study is to determine if it is possible to put into practice a cardiac screening program for survivors of Hodgkin's disease. In this study, we would also like to screen for cardiac risk factors that can be modified either through life-style changes or medications, to uncover...
What is the current status of trial NCT00165425?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2004-02. Estimated completion is 2028-12.
What conditions does trial NCT00165425 study?
This clinical trial studies the following conditions: Hodgkin's Disease.
What interventions are being tested in trial NCT00165425?
The interventions under investigation include: Echo/Stress Echo (PROCEDURE).
Who is sponsoring clinical trial NCT00165425?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00165425 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hodgkin's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00165425's enrollment target sits among peer trials
210 4th of 20 higher than 17 of 20 other Hodgkin's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hodgkin's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
COMPLETED · NA
-
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
RECRUITING · Phase 1
-
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
RECRUITING
-
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
RECRUITING
-
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
RECRUITING
-
Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia